As Ovarian and Gynecologic Cancer Awareness Month begins, Ovarian Cancer Research Alliance (OCRA) is proud to highlight a series of initiatives aimed at expanding access and promoting equity in ovarian and all gynecologic cancer care. This year’s efforts include the launch of targeted research grants to address health inequities, a new “Find a Doctor” tool to … Continued
Help OCRA Make an Impact for Ovarian Cancer and Gynecologic Cancer Awareness Month September is Ovarian Cancer Awareness Month and Gynecologic Cancer Awareness Month. As the largest non-profit in the world combating ovarian and gynecologic cancers, OCRA is committing to raise $300,000 this September to accelerate progress in research, advocate for our community, and continue … Continued
Last month, we updated you on the U.S. House of Representatives’ progress on FY2025 appropriations bills, which mostly held good news for programs related to ovarian cancer funding. Those programs all either maintained their current funding level or received small increases. The Senate also took action, but so far, none of the 12 appropriations bills … Continued
Fortune Magazine Shares OCRA’s Lifesaving Ovarian Cancer Prevention Message In light of Chris Evert’s ovarian cancer diagnosis, OCRA’s Chief Program Officer, Sarah DeFeo, and OCRA’s Scientific Advisory Committee member Dr. Gillian Hanley, spoke with Fortune Magazine about why knowing one’s risk and taking preventative action, such as fallopian tube removal at the time of planned … Continued
Last month, we updated you on recent reports indicating that the House Committee on Appropriations was considering significant cuts to health-related programs, sparking concerns that these potential cuts could impair the efforts that OCRA and our advocates have fought for over the years. Since then, the House Committee report for Labor, Health and Human Services, … Continued
OCRA’s 2024 Mentored Investigator Grants are supporting fresh perspectives and approaches to end ovarian and related gynecologic cancers. This year’s grants are awarded to 5 exceptional young researchers who are conducting promising studies under the mentorship of leaders in the gynecologic cancer field. “OCRA’s Mentored Investigators exemplify the innovative spirit and dedication needed to make … Continued
In an article titled “Amazon MGM Studios’ Debra Birnbaum Joins Ovarian Cancer Research Alliance Board,” Variety editor William Earl writes about MGM Studios’ Debra Birnbaum’s appointment to Ovarian Cancer Research Alliance’s board of directors. An ovarian cancer survivor, Debra Birnbaum talks about what inspired her to join OCRA, and what she hopes to accomplish for … Continued
In light of Chris Evert’s ovarian cancer diagnosis, OCRA’s Chief Program Officer, Sarah DeFeo, spoke with Fortune Magazine about why knowing risk and taking preventative action can save lives, and about OCRA’s free genetic testing kit program for those at increased risk. Read the article, “With ovarian cancer, there’s no such thing as early detection. … Continued
Amazon MGM Studios’ Debra Birnbaum, Media Visionary & Ovarian Cancer Survivor, Joins OCRA Board of Directors Ovarian Cancer Research Alliance is proud to announce that Debra Birnbaum has joined its Board of Directors. Birnbaum is an accomplished multi-platform content creator and media strategist with over 20 years of experience covering news and entertainment, and the current global … Continued
June is Uterine Cancer Awareness Month and OCRA is dedicated to fighting on behalf of not only the ovarian cancer community but the entire gynecologic cancer community. Uterine cancer is the most common gynecologic cancer in high-income countries, and around 90% of uterine cancers are endometrial cancer types — one of the few cancers experiencing … Continued
The potential to help even one person serves as a powerful motivator for ovarian cancer survivor Marlynn Olivarez and gym owner Krista Iglesias Thomas, two OCRA Heroes who are wholeheartedly devoted to raising funds for ovarian cancer research and bringing more awareness to the disease. “If one life is saved, it’s totally worth it,” said … Continued
OCRA’s 2024 Early Career Investigator Grants are awarded to 8 outstanding young researchers with a strong commitment to ending ovarian and related gynecologic cancers. These grants fund innovative projects, and support the next generation of scientists dedicated to curing ovarian cancer. “By supporting these early career investigators, we’re fostering innovative approaches and fresh perspectives into … Continued
Get email updates about research news, action alerts, and ways to join the fight.
